Idorsia aims to be Europe’s leading biopharmaceutical company, with a strong scientific core. We provide regular updates on the progress being made towards this goal. This section of the website provides journalists with additional material to support the generation of articles.

Events

Event When
J.P. Morgan Healthcare conference

Press Release (Link); Presentation (Audio streamPDF)

BofA Securities SMID Cap Conference January 12-13, 2021
Baader Helvea Swiss Equities Conference January 14, 2021
Octavian Seminar Flims January 14-17, 2021
Full-Year 2020 Financial Results reporting* February 4, 2021
Credit Suisse Global Healthcare Conference March 2-4, 2021
Barclay's Global Healthcare Conference March 9-11, 2021
Jefferies Pan-EU Mid-Cap Conference March 30-April 1, 2021
First Quarter 2021 Financial Results reporting* April 22, 2021
Annual General Meeting of Shareholders May 12, 2021
Half-Year 2021 Financial Results reporting* July 27, 2021

*We will be in a silent period for 10 days ahead of the financial reporting.

Stay informed

Idorsia offers an electronic ‘Stay Informed’ service where subscribers can automatically receive updates via e-mail or SMS alert.

Stay informed

Social Media

Idorsia is active on social media – follow our channels to get a more personal view on the company.

Social Media

Media center

Idorsia provides images, fact sheets and B-roll to download or support you with your article.

Media center

Contact

Contact

Andrew C. Weiss

Senior Vice President, Head of Investor Relations and Corporate Communications

Media Relations

Resources in German

Als schweizerisches Unternehmen stellen wir interessierten Personen auf dieser Seite wesentliche Informationen über unser Unternehmen in deutscher Sprache zur Verfügung.